News

A new AI precision medicine test is being used to help clinicians better identify a personalized treatment plan to treat ...
Breast cancer survivors who lost ≤5% of body weight with diet and exercise experienced greater weight loss, improved function ...
Data show that the cancer vaccine Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival in ...
A nationwide survey of patients and caregivers has found educational and financial disparities in brain cancer care.
The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer. The U.S. Food and ...
Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person's risk for ...
Intensive chemotherapy improved survival in patients with accelerated and blast phase myeloproliferative neoplasms, with ...
A diagnosis of breast cancer isn’t something most people would think of as a teacher, but sometimes important lessons come to ...
It is important to expand clinical trial access for patients with kidney cancer in order to ensure a representative study population.
Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly ...